MEIZHU CHEN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BROOKLYN, NY NPI 1770152969
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NY Acerta Pharma LLC All categories
General Payments — all program years on this page
$2,485.31
- Category: General Payments
- Program years: PY2022–2024
- Record count: 64
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,201.61 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,913.62 | 59 |
| Education | $287.99 | 3 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $355.98 | 7 |
| Janssen Biotech, Inc. | $310.74 | 7 |
| Incyte Corporation | $267.60 | 9 |
| Merck Sharp & Dohme Corporation | $267.05 | 7 |
| Coherus Biosciences Inc. | $148.12 | 1 |
| Exelixis Inc. | $135.00 | 1 |
| EISAI INC. | $123.19 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $77.64 | 3 |
| TAIHO ONCOLOGY, INC. | $77.32 | 3 |
| Daiichi Sankyo Inc. | $72.51 | 3 |
| Blueprint Medicines Corporation | $64.78 | 2 |
| Karyopharm Therapeutics Inc. | $60.34 | 2 |
| Mirati Therapeutics, Inc. | $56.78 | 3 |
| Lilly USA, LLC | $43.99 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $34.92 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.67 | 1 |
| Gilead Sciences, Inc. | $22.62 | 1 |
| Kyowa Kirin, Inc. | $21.99 | 1 |
| PFIZER INC. | $20.08 | 1 |
| Astellas Pharma US Inc | $13.29 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.